Sort   by:  
 Page size 
UnknownEnzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer.
Not available
S-EPMC5858523 | biostudies-literature
UnknownTargeting the androgen receptor in triple-negative breast cancer.
Not available
S-EPMC5580391 | biostudies-literature
UnknownTargeting obesity-related adipose tissue dysfunction to prevent cancer development and progression.
Not available
S-EPMC4789163 | biostudies-literature
UnknownMale breast cancer: a disease distinct from female breast cancer.
Not available
S-EPMC7513797 | biostudies-literature
UnknownPhase 1 study of seviteronel, a selective CYP17 lyase and androgen receptor inhibitor, in women with estrogen receptor-positive or triple-negative breast cancer.
Not available
S-EPMC6226357 | biostudies-literature
UnknownEvolving Concepts: Immunity in Oncology from Targets to Treatments.
Not available
S-EPMC4427847 | biostudies-literature
UnknownLeptin regulation of the p53-HIF1α/PKM2-aromatase axis in breast adipose stromal cells: a novel mechanism for the obesity-breast cancer link.
Not available
S-EPMC5936686 | biostudies-literature
UnknownSecondhand Smoke Exposure Among Community-Dwelling Adult Cancer Survivors in the United States: 1999-2012.
Not available
S-EPMC5671647 | biostudies-literature
UnknownExploring causes and consequences of early discontinuation of durvalumab after chemoradiotherapy for non-small cell lung cancer.
Not available
S-EPMC10279777 | biostudies-literature
UnknownA Randomized Multicenter Phase II Study of Docosahexaenoic Acid in Patients with a History of Breast Cancer, Premalignant Lesions, or Benign Breast Disease.
Not available
S-EPMC6290902 | biostudies-literature
Sort   by:  
 Page size